News: agreement

VivaZome licenses University of Adelaide stem cell technology

Our collaboration with VivaZome demonstrates the University’s commitment to investigator-led research.

Posted on May 12 2020 by Elisa Black

VivaZome Therapeutics and the University of Adelaide have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.

[Read more about VivaZome licenses University of Adelaide stem cell technology]